The authors reply
Main Authors: | Chapman, D, Judge, PK, Arnold, T, Staplin, N, Clark, S, Haynes, R, Moffat, S, Herrington, WG, Hill, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Elsevier
2023
|
Títulos similares
-
Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study
por: Judge, PK, et al.
Publicado: (2023) -
Allocated but not treated: the silent 16% – Authors' reply
por: Horby, P, et al.
Publicado: (2022) -
Authors' reply
por: Herrington, W, et al.
Publicado: (2018) -
Impact of primary kidney disease on the effects of empagliflozin in patients with CKD
por: Judge, PK, et al.
Publicado: (2023) -
The prevention and management of chronic kidney disease among patients with metabolic syndrome
por: Zhu, D, et al.
Publicado: (2025)